Substance P primes lipoteichoic acid- and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2

Immunology

Volumn 131, Issue 2, 2010, Pages 220-230

  Tancowny, Brian P ^a   Karpov, Victor ^b   Schleimer, Robert P ^a   Kulka, Marianna ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

chemokines; immunoglobulin E; mast cells; neuropeptides; substance P; vasoactive intestinal peptide

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CHEMOKINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LEUKOTRIENE C4; LIPOTEICHOIC ACID; LIPOXYGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN C JUN; SUBSTANCE P; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CELL ACTIVATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFECTION SENSITIVITY; INNATE IMMUNITY; MAST CELL; MAST CELL DEGRANULATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ARACHIDONATE 5-LIPOXYGENASE; CELL DEGRANULATION; CELL LINE; CHEMOKINES; CYTOKINES; DRUG SYNERGISM; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; LEUKOTRIENE C4; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MAST CELLS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SUBSTANCE P; TEICHOIC ACIDS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 77956332289     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03296.x     Document Type: Article

References (37)

1. Milner P, Ralevic V, Hopwood AM, Feher E, Lincoln J, Kirkpatrick KA, Burnstock G. Ultrastructural localisation of substance P and choline acetyltransferase in endothelial cells of rat coronary artery and release of substance P and acetylcholine during hypoxia. Experientia 1989 45 : 121 125.
2. Ho WZ, Lai JP, Zhu XH, Uvaydova M, Douglas SD. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 1997 159 : 5654 5660.
3. Lai JP, Douglas SD, Rappaport E, Wu JM, Ho W. Identification of a delta isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytes. J Neuroimmunol 1998 91 : 121 128.
4. Lambrecht BN, Germonpre PR, Everaert EG et al. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol 1999 29 : 3815 3825.
5. Sterner-Kock A, Braun RK, van der Vliet A, Schrenzel MD, McDonald RJ, Kabbur MB, Vulliet PR, Hyde DM. Substance P primes the formation of hydrogen peroxide and nitric oxide in human neutrophils. J Leukoc Biol 1999 65 : 834 840.
6. Tominaga K, Honda K, Akahoshi A, Makino Y, Kawarabayashi T, Takano Y, Kamiya H. Substance P causes adhesion of neutrophils to endothelial cells via protein kinase C. Biol Pharm Bull 1999 22 : 1242 1245.
7. Kincy-Cain T, Bost KL. Increased susceptibility of mice to Salmonella infection following in vivo treatment with the substance P antagonist, spantide II. J Immunol 1996 157 : 255 264.
8. Lighvani S, Huang X, Trivedi PP, Swanborg RH, Hazlett LD. Substance P regulates natural killer cell interferon-gamma production and resistance to Pseudomonas aeruginosa infection. Eur J Immunol 2005 35 : 1567 1575.
9. Kincy-Cain T, Bost KL. Substance P-induced IL-12 production by murine macrophages. J Immunol 1997 158 : 2334 2339.
10. Cooper KG, Zarnowski R, Woods JP. Histoplasma capsulatum encodes a dipeptidyl peptidase active against the mammalian immunoregulatory peptide, substance P. PLoS ONE 2009 4 : e5281.
11. Hansen CJ, Burnell KK, Brogden KA. Antimicrobial activity of substance P and neuropeptide Y against laboratory strains of bacteria and oral microorganisms. J Neuroimmunol 2006 177 : 215 218.
12. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 2005 3 : 238 250.
13. Tossi A. Host defense peptides: roles and applications. Curr Protein Pept Sci 2005 6 : 1 3.
14. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002 415 : 389 395.
15. Grissell TV, Chang AB, Gibson PG. Reduced toll-like receptor 4 and substance P gene expression is associated with airway bacterial colonization in children. Pediatr Pulmonol 2007 42 : 380 385.
16. Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 2008 123 : 398 410.
17. Kirshenbaum AS, Akin C, Wu Y, Rottem M, Goff JP, Beaven MA, Rao VK, Metcalfe DD. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res 2003 27 : 677 682.
18. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002 3 : RESEARCH0034.
19. Kulka M, Metcalfe DD. TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Mol Immunol 2006 43 : 1579 1586.
20. McCurdy JD, Olynych TJ, Maher LH, Marshall JS. Cutting edge: distinct toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 2003 170 : 1625 1629.
21. Qiao H, Andrade MV, Lisboa FA, Morgan K, Beaven MA. FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 2006 107 : 610 618.
22. Schoniger S, Maronde E, Kopp MD, Korf HW, Nurnberger F. Transcription factor CREB and its stimulus-dependent phosphorylation in cell and explant cultures of the bovine subcommissural organ. Cell Tissue Res 2002 308 : 131 142.
23. Wang H, Garcia CA, Rehani K, Cekic C, Alard P, Kinane DF, Mitchell T, Martin M. IFN-beta production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-beta. J Immunol 2008 181 : 6797 6802.
24. Schaaf B, Luitjens K, Goldmann T, van Bremen T, Sayk F, Dodt C, Dalhoff K, Droemann D. Mortality in human sepsis is associated with downregulation of Toll-like receptor 2 and CD14 expression on blood monocytes. Diagn Pathol 2009 4 : 12.
25. Melkamu T, Squillace D, Kita H, O'Grady SM. Regulation of TLR2 expression and function in human airway epithelial cells. J Membr Biol 2009 229 : 101 113.
26. Leemans JC, Butter LM, Pulskens WP, Teske GJ, Claessen N, van der Poll T, Florquin S. The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS ONE 2009 4 : e5704.
27. Richard KL, Filali M, Prefontaine P, Rivest S. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J Neurosci 2008 28 : 5784 5793.
28. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol 2004 201 : 167 180.
29. Weinstock JV, Blum A, Walder J, Walder R. Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P. J Immunol 1988 141 : 961 966.
30. Lambrecht BN. Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation. Respir Res 2001 2 : 133 138.
31. Burg M, Zahm DS, Knuepfer MM. Immunocytochemical co-localization of substance P and calcitonin gene-related peptide in afferent renal nerve soma of the rat. Neuroscience letters 1994 173 : 87 93.
32. Fehrenbach K, Port F, Grochowy G et al. Stimulation of mast cells via FcvarepsilonR1 and TLR2: the type of ligand determines the outcome. Mol Immunol 2007 44 : 2087 2094.
33. Heib V, Becker M, Taube C, Stassen M. Advances in the understanding of mast cell function. Br J Haematol 2008 142 : 683 694.
34. Garza A, Weinstock J, Robinson P. Absence of the SP/SP receptor circuitry in the substance P-precursor knockout mice or SP receptor, neurokinin (NK)1 knockout mice leads to an inhibited cytokine response in granulomas associated with murine Taenia crassiceps infection. J Parasitol 2008 94 : 1253 1258.
35. Svensson A, Kaim J, Mallard C, Olsson A, Brodin E, Hokfelt T, Eriksson K. Neurokinin 1 receptor signaling affects the local innate immune defense against genital herpes virus infection. J Immunol 2005 175 : 6802 6811.
36. Walsh DT, Weg VB, Williams TJ, Nourshargh S. Substance P-induced inflammatory responses in guinea-pig skin: the effect of specific NK1 receptor antagonists and the role of endogenous mediators. British journal of pharmacology 1995 114 : 1343 1350.
37. Joachim RA, Handjiski B, Blois SM, Hagen E, Paus R, Arck PC. Stress-induced neurogenic inflammation in murine skin skews dendritic cells towards maturation and migration: key role of intercellular adhesion molecule-1/leukocyte function-associated antigen interactions. Am J Pathol 2008 173 : 1379 1388.